Sodium Hydroxide → HCID 13854113, compound
Reaction equation
C([O:3][C:4]([C@@H:6]([NH:15][C@H:16]1[CH2:22][S:21][CH:20]([C:23]2[S:24][CH:25]=[CH:26][CH:27]=2)[CH2:19][N:18]([CH2:28][C:29]([OH:31])=[O:30])[C:17]1=[O:32])[CH2:7][CH2:8][C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1)=[O:5])C.[OH-].[Na+]>>[C:4]([C@@H:6]([NH:15][C@H:16]1[CH2:22][S:21][CH:20]([C:23]2[S:24][CH:25]=[CH:26][CH:27]=2)[CH2:19][N:18]([CH2:28][C:29]([OH:31])=[O:30])[C:17]1=[O:32])[CH2:7][CH2:8][C:9]1[CH:10]=[CH:11][CH:12]=[CH:13][CH:14]=1)([OH:5])=[O:3]Participants
3
Procedure
The procedure described in Example 44 was repeated, except that 80 mg of α-{6(R)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl}acetic acid (prepared as described in Example 64) were used as the starting material. After hydrolysis of the starting material with sodium hydroxide, 65 mg of the title compound were obtained as a powder.
Sources & evidence
- ORD record
- ord-467f9ff619064c4ca280a80ad94578f6
- Source dataset
- uspto-grants-1987_10
- Patent number
- US04699905
Reaction notes
Loading…